...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The best I can make it from financials/MD&A:

Balance, April 30,    2021, 135,302,493
Balance, April 30,    2022, 136,514,414 (fully diluted 150,053,009)
Balance, April 30,    2023, 148,499,462 (fully diluted 175,441,194)
Balance, Sept 27,    2023, 152,219,369  (fully diluted 184,683,974)

 

Koo

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply